Trending Topic

4 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest edition of touchREVIEWS in Respiratory & Pulmonary Diseases. As we continually strive to deliver cutting-edge research and insightful commentary, this issue is no exception, featuring a diverse array of articles that illuminate both emerging treatments and evolving practices within the field of respiratory and pulmonary medicine. We begin with a compelling […]

Akio Niimi, ERS 2019 – Novel P2X3 Receptor Antagonist S-600918 in Chronic Cough

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 15th 2019

Akio Niimi, of Nagoya City University, Japan, spoke to us at ERS 2019 in Madrid about a study of a novel P2X3 receptor antagonist S-600918 in patients with refractory chronic cough.

Questions
1. What are the most common causes of chronic cough? (0:05)
2. What is the mechanism of action of S-600918? (0:34)
3. Could you tell us about the recent Phase II study and its findings? (1:34)
4. How does S-600918 differ from other P2X3 receptor antagonists? (2:22)
5. Which patients are most likely to respond to this treatment and in whom is it contraindicated? (2:54)

Speaker disclosures: Akio Niimi has nothing to disclose in relation to this video interview.

touchRESPIRATORY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.

Filmed at the European Respiratory Society (ERS) International Congress 2019, Madrid, Spain.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup